Skip to Main Content
Tiffany Simms-Waldrip, M.D.

Tiffany Simms-Waldrip, M.D.

Titles and Appointments

Clinical Associate Professor

Schools
Medical School
Departments
Pediatrics

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Tiffany Simms-Waldrip, M.D., is an Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. She specializes in pediatric hematology-oncology and focuses her research on hematopoietic stem cell transplant, transplant for bone marrow failure syndromes, and graft-versus-host disease.

    Dr. Simms-Waldrip earned her medical degree at Texas Tech University Health Sciences Center. She performed her residency in pediatrics at UCLA Medical Center, where she also completed a fellowship in pediatric hematology-oncology.

    Certified by the American Board of Pediatrics in pediatric hematology-oncology, she joined the UT Southwestern faculty in 2010.

    Dr. Simms-Waldrip is the Clinical Director of Pediatric Hematopoietic Stem Cell Transplant (HSCT) at UT Southwestern and Children’s Medical Center Dallas. She also serves as the HSCT Education Coordinator and HSCT Bone Marrow Failure Physician at both institutions.

    She is a member of the American Society for Transplantation and Cellular Therapy and serves on numerous committees, including as Chair of the Tissue and Transfusion Utilization Committee at Children’s. In addition, she is a Pediatrics Residency Program mentor at UTSW.

    She has published numerous academic articles.

  • Education
    Medical School
    Texas Tech University Health Sciences Center (2004)
    Residency
    University of California, Los Angeles (2007), Pediatrics
    Fellowship
    University of California, Los Angeles (2010), Pediatric Hematology/oncology
  • Research Interest
    • Graft-versus-host disease
    • Hematopoiesis
    • Transplantation in bone marrow failure syndromes
  • Publications
    Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes
    Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman RE, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel PA, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds Jr. RR, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X Transplantation and Cellular Therapy 2022 Feb 28 113.e1-113.e8
    Invasive fungal infections while on voriconazole, liposomal amphotericin B, or micafungin for antifungal prophylaxis in pediatric stem cell transplant patients
    Bui A, Nguyen V, Hsu C, Hyde B, Simms-Waldrip T Journal of Pediatric Pharmacology and Therapeutics 2019 May 24 220-226
    Food for Gut: Microbiota Fuels Immune Reconstitution after BMT
    Simms-Waldrip TR, Koh AY Cell Host and Microbe 2018 Apr 23 423-424
    Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients
    Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh A Biology of Blood and Marrow Transplantation 2017 May 23 820-829
    Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization
    Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh A Nature medicine 2015 Jul 21 808-814
    Invasive fungal infections in pediatric hematopoietic stem cell transplant patients
    Simms-Waldrip T, Rosen G, Nielsen-Saines K, Ikeda A, Brown B, Moore T Infectious Diseases 2015 47 218-224
    Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT
    Simms-Waldrip T, Ikeda A, Goldfinger D, Moore T, Yuan S Bone Marrow Transplantation 2010 Jan 45 201-202
    Corrigendum to "The aggresome pathway as a target for therapy in hematologic malignancies" [Mol. Genet. Metab. 94 (2008) 283-286] (DOI:10.1016/j.ymgme.2008.03.012)
    Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM Molecular Genetics and Metabolism 2009 Jun 97 164
    The aggresome pathway as a target for therapy in hematologic malignancies
    Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM Molecular Genetics and Metabolism 2008 Jul 94 283-286
    Role of the aggresome pathway in cancer: Targeting histone deacetylase 6-dependent protein degradation
    Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM Cancer research 2008 Apr 68 2557-2560
  • Honors & Awards
    • ASBMT Clinical Research Training Scholar
      (2011)
    • NIH T32 Developmental Hematology Training Grant
      (2008)
    • AAP Resident Research Grant
      (2006)
    • Magna Cum Laude, Texas Christian University
      (2000)
  • Professional Associations/Affiliations
    • American Society for Transplantation and Cellular Therapy (2010)
    • American Society of Pediatric Hematology/Oncology (2009-2012)